MedTrace Logo

The Effect of Different Degree of Temperature on Levobupivacaine Spinal Anesthesia

NCT03790163 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2019-01-02

No results posted yet for this study

Summary

This study will be conducted to evaluate the effect of different temperature on the spinal anesthesia characteristics and incidence of complications

Conditions

  • Spinal Anesthetic Toxicity

Interventions

DRUG

Levobupivacaine

Drug: levobupivacaine at room temperature ( 23˚C) and second group levobupivacaine warmed to the (30˚C) while the third group levobupivacaine warmed to the body temperature (37˚C)

Sponsors & Collaborators

  • Mansoura University Hospital

    lead OTHER

Principal Investigators

  • Reem El sharkawy · lecturer of anesthesia and surgical intensive care ,faculty of medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-15
Primary Completion
2019-03-31
Completion
2019-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03790163 on ClinicalTrials.gov